Source: News Bites
Published 4:08 PM, 9 Aug 2010
Source: News Bites
http://www.businessspectator.com.au/bs.nsf/Article/Virax-awaiting-HIV-vaccine-trial-results-869CS?opendocument&src=rss
Virax Holdings Ltd is awaiting results from the phase IIa cinical trial in South Africa for its HIV therapeutic vaccine, VIR201.
All immunological laboratory analyses have been completed and data input into the clinical trial database.
Results are expected in 1-2 weeks.
VIR201 treats HIV-infected individuals by lowering viral load. Current HIV treatments typically use a combination of antiretroviral therapies which often have unwanted side effects.
Source: News BitesPublished 4:08 PM, 9 Aug 2010 Source: News...
Add to My Watchlist
What is My Watchlist?